Business Insider

Persistent Epithelial Defect (PED) Epidemiology Insights 2017-2030 - Unmet Needs, SWOT Analysis, Case Studies, KOL Views and More

Dublin, July 13, 2020 (GLOBE NEWSWIRE) -- The "Persistent Epithelial Defect (PED) - Epidemiology Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in ...

Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035

Market is poised for steady growth due to rising prevalence of corneal disorders, adoption of advanced therapies, and increasing awareness of ocular health. PED, a rare ocular condition, requires ...
Healio

Patient history, exam key to treating persistent epithelial defects

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ophthalmologists need to look and listen for the cause of persistent epithelial defects, according ...
Monthly Prescribing Reference

MCS-S Therapy Fast Tracked for Persistent Corneal Epithelial Defect

Credit: Thinkstock. KPI-012 is a topically dosed ophthalmic therapy designed using the Company's human mesenchymal stem cell secretome platform. The Food and Drug Administration (FDA) has granted Fast ...
Mena FN

Persistent Corneal Epithelial Defects Treatment Pipeline Shows Strong Momentum As 5+ Pharma Companies In The Race Delveinsight

DelveInsight's “Persistent Corneal Epithelial Defects Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Persistent Corneal Epithelial Defects ...